MedPath
HSA Approval

CEFAZIME FOR INJECTION 1 g/vial

SIN11470P

CEFAZIME FOR INJECTION 1 g/vial

CEFAZIME FOR INJECTION 1 g/vial

March 26, 2001

ZYFAS MEDICAL CO

ZYFAS MEDICAL CO

Regulatory Information

HSA regulatory responsibility and product classification details

Regulatory Responsibility

RegistrantZYFAS MEDICAL CO
Licence HolderZYFAS MEDICAL CO

Product Classification

D
Drug Type
Therapeutic
F
Forensic Class
Prescription Only
HSA Singapore Classification

Formulation Information

INJECTION

INTRAVENOUS, INTRAMUSCULAR

Medical Information

J01DD02

ceftazidime

Manufacturer Information

ZYFAS MEDICAL CO

CJ CORP

Active Ingredients

CEFTAZIDIME PENTAHYDRATE EQV CEFTAZIDIME

1 g/vial

Ceftazidime

SODIUM CARBONATE

121 mg/vial

Sodium carbonate

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

CEFAZIME FOR INJECTION 1 g/vial - HSA Approval | MedPath